Archive · 23 Dec 2025
Gujarat Kidney IPO Sees Strong Subscription
Gujarat Kidney & Super Speciality, a company that runs hospitals and pharmacies in Gujarat, is selling shares to the public for the first time.
Many people wanted to buy these shares, and on the second day, they got more than twice as many requests as they had shares to sell.
The shares are priced between Rs 108 and Rs 114 each.
Some people think this is a good chance to invest because healthcare is important and growing.
But others are careful because the company is still new and needs to keep growing to be worth the price.
The shares will start being traded on December 30, 2025.
Gujarat Kidney & Super Speciality's IPO saw a strong response, with overall subscription reaching 2.52 times by the second day.
The IPO, priced between Rs 108-114 per share, aims to raise Rs 250.80 crore through a fresh issue of 2,20,00,000 equity shares.
Retail investor portion was subscribed 9.82 times, while non-institutional investors saw a subscription of 2.73 times.
The grey market premium for the shares is Rs 3-4, suggesting potential listing gains of 3-4%.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds.
- Who
- Gujarat Kidney & Super Speciality, a healthcare provider with seven multispeciality hospitals and four pharmacies in Gujarat, India.
- What
- Initial public offering (IPO) subscription and bidding details.
- When
- December 22-24, 2025 (bidding period), with listing on December 30, 2025.
- Where
- India, with shares to be listed on BSE and NSE.
- Why
- To raise Rs 250.80 crore via a fresh issue of 2,20,00,000 equity shares.
Optimistic View
Cautious View
Investment Potential
Optimistic View
Gujarat Kidney & Super Speciality is well positioned to benefit from rising healthcare demand and favorable industry tailwinds, making it a potential long-term investment opportunity.
Cautious View
The company has a limited operating history and needs to maintain high growth to justify its valuation, which warrants caution from a long-term perspective.
- Company
- Gujarat Kidney & Super Speciality
- IPO Size
- Rs 250.80 crore
- Price Range
- Rs 108-114 per share
- Subscription Rate (Day 2)
- 2.52 times overall
- Retail Subscription
- 9.82 times
- NII Subscription
- 2.73 times
- QIB Subscription
- 34%
- Grey Market Premium
- Rs 3-4 per share
- Listing Date
- December 30, 2025
- Exchanges
- BSE, NSE